Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc
about
P1343
RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells.Detection of amino-terminal extracellular domain of somatostatin receptor 2 by specific monoclonal antibodies and quantification of receptor density in medulloblastoma.In comparative analysis of multi-kinase inhibitors for targeted medulloblastoma therapy pazopanib exhibits promising in vitro and in vivo efficacy.Molecular characterization of the pediatric preclinical testing panelNovel agents targeting the IGF-1R/PI3K pathway impair cell proliferation and survival in subsets of medulloblastoma and neuroblastoma.The Phosphoinositide 3-Kinase p110α Isoform Regulates Leukemia Inhibitory Factor Receptor Expression via c-Myc and miR-125b to Promote Cell Proliferation in Medulloblastoma.Effects of basic fibroblast growth factor on the differentiation, growth, and viability of a new human medulloblastoma cell line (UM-MB1).Phosphate-dependent and independent neurofilament protein epitopes are expressed throughout the cell cycle in human medulloblastoma (D283 MED) cells.Co-expression of low molecular weight neurofilament protein and glial fibrillary acidic protein in established human glioma cell linesBarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma.Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours.Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma.IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma.Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cellsMolecular diagnostics of CNS embryonal tumors.The gene expression profiles of medulloblastoma cell lines resistant to preactivated cyclophosphamide.Characterization of novel biomarkers in selecting for subtype specific medulloblastoma phenotypes.p53 and Meduloblastoma.OTX2 exhibits cell-context-dependent effects on cellular and molecular properties of human embryonic neural precursors and medulloblastoma cells.The PI3K inhibitor GDC-0941 displays promising in vitro and in vivo efficacy for targeted medulloblastoma therapy[Lu]-DOTA-Tyr-octreotate: A Potential Targeted Radiotherapeutic for the Treatment of Medulloblastoma.Experimental production of primitive neuroectodermal tumors and its relevance to human neuro-oncology.The anti-neoplastic activity of Vandetanib against high-risk medulloblastoma variants is profoundly enhanced by additional PI3K inhibitionN-myc gene expression and oncoprotein characterisation in medulloblastomaNerve growth factor receptor expression in peripheral and central neuroectodermal tumors, other pediatric brain tumors, and during development of the adrenal gland.Characterization of a novel OTX2-driven stem cell program in Group 3 and Group 4 medulloblastoma.Stimulation of medulloblastoma stem cells differentiation by a peptidomimetic targeting neuropilin-1.
P2860
Q33398834-820B2C8A-A3BB-43F1-A745-33C9A301EF94Q33788867-6165CA8A-D9C5-4258-BF2D-64C80110A231Q34334533-D00EAAEA-EA78-49A3-9D6C-A7F67126D614Q34406965-EFA1317C-F637-4923-B1AB-4F4B42E3EC0DQ34442835-5B9B7146-4F24-4970-BA50-FDD5321169BDQ35542600-6DB7ABA5-04DC-42DF-8F0C-8D97A263DE4AQ35763427-98B75E39-B79B-4B79-AD91-382431DD9187Q35817141-A65145B7-F365-490E-B4A8-F3DF6DF1B282Q35832410-C9ADACD7-0CD6-4F51-866E-BD136593515AQ36054158-48204636-F8D1-4E86-8F54-276152EC4AE6Q36387895-E517591D-B905-4BC2-811B-E345C6693E0EQ36655904-CC4DE113-2EF9-4C70-A605-D50DE8D683B6Q36965081-9256EA63-D711-4B16-AAF6-CB2B7DB7952DQ37257512-FE52698C-539C-4AE6-8283-B9F66F0B4FD4Q37794829-5D278E4F-61AB-47A8-A6EA-9982CB96D15FQ38291073-45C52E59-B2A1-430C-B446-F7AED53A5626Q38673687-E2E0FC48-85B5-4D94-B5A2-1FE28E15E5D1Q38673795-B90E29D4-D881-4ECA-8DE5-2E37784BD857Q38833100-B4784F01-52CD-4C9F-BE56-17DBA5788777Q38919020-F493D7D1-624B-4493-8CBF-E8A854968BC8Q39606627-022408B5-5287-48BD-8633-8092CAC216F3Q40725279-A066580E-8307-49E5-9654-D15CD3021F5FQ41470815-27A063E9-6EC9-460B-A9DC-FDE7E93DEA78Q41775723-D3D6372B-23CD-4D81-A40D-49A55BCF1B65Q42160111-222D3575-0045-47E0-BF0B-02E53CF7A1FDQ47551116-38218C9C-AF62-4878-B964-4BF9248D084CQ52597602-D2974433-C4D7-44C1-BA1B-C016689C1015
P2860
Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Phenotypic and genotypic analy ...... trating amplification of c-myc
@ast
Phenotypic and genotypic analy ...... trating amplification of c-myc
@en
type
label
Phenotypic and genotypic analy ...... trating amplification of c-myc
@ast
Phenotypic and genotypic analy ...... trating amplification of c-myc
@en
prefLabel
Phenotypic and genotypic analy ...... trating amplification of c-myc
@ast
Phenotypic and genotypic analy ...... trating amplification of c-myc
@en
P2093
P2860
P921
P1476
Phenotypic and genotypic analy ...... trating amplification of c-myc
@en
P2093
C J Wikstrand
E C Halperin
G M Brodeur
J Kurtzberg
J Q Trojanowski
M E Berens
P C Burger
S H Bigner
P2860
P304
P407
P4510
P577
1988-03-01T00:00:00Z